In silico identification of widely used and well-tolerated drugs as potential SARS-CoV-2 3C-like protease and viral RNA-dependent RNA polymerase inhibitors for direct use in clinical trials

Despite strict measures taken by many countries, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to be an issue of global concern. Currently, there are no clinically proven pharmacotherapies for coronavirus disease 2019, despite promising initial results obtained from drugs su...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Biomol Struct Dyn
Hlavní autoři: Gul, Seref, Ozcan, Onur, Asar, Sinan, Okyar, Alper, Barıs, Ibrahim, Kavakli, Ibrahim Halil
Médium: Artigo
Jazyk:Inglês
Vydáno: Taylor & Francis 2020
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7484590/
https://ncbi.nlm.nih.gov/pubmed/32752938
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/07391102.2020.1802346
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky